Catalyst Pharmaceuticals, Inc.

NasdaqCM:CPRX Stock Report

Market Cap: US$2.5b

Catalyst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CPRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Aug 24SellUS$3,052,900Steven MillerIndividual150,000US$20.59
09 Aug 24SellUS$111,710Jeffrey Del CarmenIndividual6,058US$18.44
07 Jun 24SellUS$121,184Jeffrey Del CarmenIndividual7,541US$16.07
03 Jun 24SellUS$86,949Molly HarperIndividual5,333US$16.30
27 Mar 24SellUS$411,000Brian ElsberndIndividual25,000US$16.44
15 Dec 23SellUS$57,720Molly HarperIndividual4,000US$14.43
05 Dec 23SellUS$569,600Steven MillerIndividual40,000US$14.24

Insider Trading Volume

Insider Buying: CPRX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CPRX?
Owner TypeNumber of SharesOwnership Percentage
State or Government48,3940.0406%
Hedge Funds6,229,6345.22%
Individual Insiders7,074,7825.93%
General Public14,253,71112%
Institutions91,666,91576.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.9%.

Top Shareholders

Top 25 shareholders own 63.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
BlackRock, Inc.
19,016,873US$391.7m1.72%0.01%
6.74%
The Vanguard Group, Inc.
8,040,978US$165.6m-0.73%no data
5.22%
Deerfield Management Company, L.P. Series C
6,229,634US$128.3m-31.8%2.34%
4.77%
State Street Global Advisors, Inc.
5,685,330US$117.1m-5.77%no data
3.75%
Patrick McEnany
4,478,169US$92.3m0%no data
2.53%
Dimensional Fund Advisors LP
3,018,789US$62.2m0.6%0.01%
2.35%
Pacer Advisors, Inc.
2,804,013US$57.8m-5.51%0.14%
2.23%
Geode Capital Management, LLC
2,664,424US$54.9m-1.27%no data
2.12%
Renaissance Technologies LLC
2,526,016US$52.0m16.1%0.08%
2.04%
First Trust Advisors LP
2,428,973US$50.0m-1.78%0.04%
1.82%
Janus Henderson Group plc
2,175,641US$44.8m0%0.02%
1.69%
Royce & Associates, LP
2,021,105US$41.6m-6.52%0.37%
1.21%
Morgan Stanley, Investment Banking and Brokerage Investments
1,439,286US$29.6m92.7%no data
1.16%
Northern Trust Global Investments
1,383,800US$28.5m-0.21%no data
1.07%
Boston Partners Global Investors, Inc.
1,275,267US$26.3m-9.32%0.02%
1.03%
T. Rowe Price Group, Inc.
1,234,383US$25.4m0.12%no data
0.98%
Charles Schwab Investment Management, Inc.
1,167,743US$24.1m4.55%no data
0.96%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,139,142US$23.5m38.1%0.01%
0.92%
Goldman Sachs Group, Investment Banking and Securities Investments
1,100,696US$22.7m59%0.01%
0.89%
Jacobs Levy Equity Management Inc
1,057,390US$21.8m-21.2%0.09%
0.87%
Kennedy Capital Management LLC
1,041,416US$21.5m-18.4%0.5%
0.8%
LSV Asset Management
951,324US$19.6m8.86%0.04%
0.72%
Marshall Wace LLP
860,934US$17.7m-29.4%0.03%
0.69%
Invesco Capital Management LLC
818,333US$16.9m14.1%0.01%
0.67%
Mesirow Financial Investment Management, Inc.
800,798US$16.5m-14.3%0.27%